|
Cancer Research KI is an umbrella organisation for all cancer research at the Karolinska Institutet, and comprises around 250 research groups spanning over 22 departments and three campuses.
The overarching aim of the programme is to combine cancer research with clinical oncology in order to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society. To read more about the organisation please click here and to register for our newsletter here.
|
|
|
|
|
|
Blue Sky Grant for Innovative Cancer Research & Technology
|
|
Cancer Research KI hereby announces up to five project grants in cancer research for well-defined innovative pilot projects that aim to demonstrate proof of principle. The project should be of a "high risk – high reward" type that cannot yet attract funding from conventional funding agencies. The aim should be to obtain proof of principle and thereby provide the basis to obtain other funding. The project should not be a continuation or expansion of already funded projects.
The Blue Sky grant call is aimed for research projects relevant for the cancer field. The call is open for researchers at Karolinska Institutet (including post-docs) and the research should be performed at KI. The grant is for one year, amounts to SEK 500 000 + 25 % INDI, and can cover all kinds of project-related costs, except stipends.
|
|
Further information available here.
Deadline: 31 May, 2020
|
Translational Seed Funding Grant
|
|
Cancer Research KI hereby announces up to five project grants in cancer research to foster novel collaborations between basic and clinical scientists to address important problems in the area of translational cancer research.
The project should represent a novel genuine collaboration between two scientists: one from the field of basic cancer research and the other from the field of clinical cancer research. The two scientists should in a joint and collaborative format attack an important problem in translational cancer research, where the unique and complementary expertise from the two applicants is required to solve the research question. The project should not be a continuation or expansion of already funded projects. The grant is for one year, amounts to SEK 750 000 + 25 % INDI, and can cover all kinds of project-related costs, except stipends.
|
|
Further information available here.
Deadline: 31 May, 2020
|
Collaborative Call for Breast Cancer Applications: 2020 Karolinska Institutet and Mayo Clinic Cancer Center
|
|
The Mayo Clinic Cancer Center and Karolinska Institutet are pleased to announce the 2020 Request for Applications (RFA) within the area of breast cancer. Having created a unique network, Mayo Clinic Cancer Center and Karolinska Institutet are in an excellent position to leverage this relationship to make a global impact on cancer through research focusing on the diagnosis, prevention, or treatment of breast cancer.
Up to two individual projects will be awarded for one year with a second year of recommended funding contingent on satisfactory progress in the first year. Project investigators may request up to $100,000 (total cost) for the Mayo Clinic Cancer Center component ($50,000/year for 2 years) and up to 1MSEK for the Karolinska Institutet component (500 000SEK /year for 2 years) per project. Indirect costs are included in the total award. Funding for this RFA is through established philanthropic support (Mayo).
|
|
Further information available here.
Deadline: 15 July, 2020
|
|
|
|
|
|
|
|
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, conducted by some 250 research groups at multiple campuses and departments. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
|
|
|
|
|
|
|
